Medical

Quick Hits with Jakob Ripshtein, Chief Commercial Officer, Aphria

Jakob Ripshtein is the Chief Commercial Officer at Aphria, the Leamington, Ontario-based LP. The conversation included their nationwide distribution partners, packaging and brand-building as well as Ripshtein’s background in the spirits industry and what he brings from that industry to cannabis.

BofC24 Sept

Quick Hits with Pamela Hadfield, HelloMD

BofC connected with Pamela Hadfield, co-founder and Evangelist at HelloMD. ‍ HelloMD is on track to have the world’s largest health and wellness oriented cannabis community – and recently entered the Canadian market. ‍ Their platform has a wealth of information as well as connections to physicians in Canada that can provide insight and access to medical…

BofC11 Sept

Talking To My Parents About Medical Cannabis Isn’t Working

Over the past two years, I’ve been having an ongoing and so far unsuccessful conversation with my elderly, South Asian parents about medical cannabis and how it could potentially help them.

BofC29 Aug

Announcing Green + Silver: Cannabis and Optimal Aging

AUGUST 20, 2018, TORONTO – Cannabis is one of the most highly promising and potentially disruptive health, wellness and anti-aging therapies to become available to older Canadians in years.

BofC20 Aug

Quick Hits with Brad Rogers, President, CannTrust

CannTrust recently announced an enhancement of their partnership with generic-drug giant Apotex. Business of Cannabis connected with CannTrust President Brad Rogers to talk about what this partnership, along with supply agreements in BC, Manitoba and Alberta mean for CannTrust and the future of cannabis in Canada.

BofC14 Aug

Quick Hits with Guy Chamberland, PhD, Chief Science Officer and Interim CEO, Tetra Bio-Pharma

Guy Chamberland, PhD, Chief Science Officer and Interim CEO of Tetra Bio-Pharma joined us for a Quick Hits conversation about medical cannabis, research, development and the future of the sector in Canada and worldwide.

BofC3 Aug

Quick Hits with Nick Dean, Emblem Corp.

Nick Dean is the CEO of Emblem Corp, the Paris, Ontario-based LP. Emblem made a major acquisition this week that will increase their capacity of 3,500 percent – so we wanted to connect with Dean about the acquisition, their plan for adult-use recreational cannabis and how his past experience is providing value to Emblem.

BofC1 Aug

Quick Hits with Keith Merker, CFO, WeedMD

WeedMD has had an incredibly busy few weeks and months. In November, they announced the construction of a new greenhouse facility they were building – and recently announced the first phase of that facility is up and running.

BofC27 Jun

Jonathan Zaid, Aurora

BofC27 Jun

Keith Strachan, MediPharm Labs

BofC27 Jun

Dr. Dean Elterman

BofC27 Jun

Stephanie Karasick, Strainprint Technologies

BofC27 Jun